Clinical Trial Update: Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers [Phase 1, Phase 2]

View source ↗

Summary

Pfizer is conducting Phase 1/2 trials to evaluate PF-08634404 in combination with different anticancer agents for advanced non-small cell lung cancer. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PF-08634404

Snippet

Sponsor: Pfizer | Conditions: Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung | Phase 1, Phase 2 | Status: RECRUITING